Optima Coil System Model OPTI0520CSF10. For endovascular embolization.

FDA Device Recall #Z-1680-2022 — Class II — July 26, 2022

Recall Summary

Recall Number Z-1680-2022
Classification Class II — Moderate risk
Date Initiated July 26, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm BALT USA, LLC
Location Irvine, CA
Product Type Devices
Quantity 4 devices

Product Description

Optima Coil System Model OPTI0520CSF10. For endovascular embolization.

Reason for Recall

Products were released to customers prior to the approval and release of a test report authorizing the use of an existing material from an alternate supplier.

Distribution Pattern

U.S.: AZ and FL O.U.S.: None

Lot / Code Information

Model Number: OPTI0520CSF10 UDI-DI Code: 00818053026164 Lot Number: F220600470

Other Recalls from BALT USA, LLC

Recall # Classification Product Date
Z-0188-2026 Class I Brand Name: MEGA Ballast Distal Access Platform... Sep 25, 2025
Z-1989-2025 Class II Prestige Coil System REFs/UDI-DI codes: PRES01... May 8, 2025
Z-1988-2025 Class II Optima Coil System REFs/UDI-DI codes: OPTI0156... May 8, 2025
Z-1041-2024 Class II Neurovascular embolization device. The Optima C... Jan 3, 2024
Z-1042-2024 Class II The Prestige Coil System is a product family of... Jan 3, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.